The guidelines, released in draft in March, recommend that patients with diabetes, hypertension or cardiovascular disease be offered testing for CKD.
Urine albumin-creatinine ratio should be used to detect and identify proteinuria, although protein-creatinine ratio can be used to quantify and monitor the condition.
An ACE inhibitor should be the first choice treatment for blocking the rennin-angiotensin system, moving to an angiotensin-II receptor blocker if this is not tolerated.
If management issues arise, GPs should discuss these with a specialist.
Comment below and tell us what you think